Thank you for standing by for the Alphabet fourth quarter and fiscal year 2024 earnings conference call. At this time, all ...

Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...

Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company known for its cystic fibrosis (CF) treatments, is at a critical juncture as it seeks to diversify its portfolio and maintain its ...

The U.S. Food and Drug Administration approved a new prescription-strength pain reliever from Vertex Pharmaceuticals on Jan. 30, 2025. Journavx is a non-opioid drug that prevents peripheral nerves ...

Are you a current or former worker for a state governor’s office? We’d love to hear more ... UnitedHealthcare likely to cover Vertex’s pain drug Vertex Pharmaceuticals received FDA approval ...

Get prepared with the key expectations. Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs, and this platform has helped ...

Google dropped a bunch of Gemini announcements, including broader availability of its reasoning model and the flagship Gemini ...

Cost of Tariffs: How increases on imported goods will impact Ohio, Kentucky and Indiana residents Ye shocked at the Grammys ...

Kids 7-12 years participate in Art in Alley class lead by Annie Warmke, standing amid the children, at the Washington County Public Library. Saturday classes run through April. A community art ...

Best Picture commentary (Updated Feb. 5, 2025): This weekend, three major guilds — the Critics Choice Awards (whose final voting closed Jan. 10, before the whole “Emilia Pérez” drama), the ...

Look closely at this image, stripped of its caption, and join the moderated conversation about what you and other students see. By The Learning Network Look closely at this image, stripped of ...